Search - tctmd.com

Displaying 601 - 620 of 709

Sort: Relevancy | Date

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Industry News

U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)

January 24, 2016

News Daily News

Refreshed Dietary Guidelines Shift Focus to Healthy Eating Patterns

Todd Neale

January 18, 2016

News Daily News

膳食指南更新版的焦点转向健康饮食习惯

Todd Neale

January 18, 2016

News Daily News

La Actualización de las Directrices sobre la Dieta Cambia el Centro de Atención a Patrones Alimenticios Saludables

Todd Neale

January 18, 2016

News Daily News

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Michael O'Riordan

January 12, 2016

News Daily News

People Consuming More Sugary Drinks Gain More Visceral Fat Over Time

Todd Neale

January 10, 2016

News Daily News

Sweet Surrender? Trimming Sweetness from Sugary Drinks May Cut Obesity-Related Diseases

Todd Neale

January 06, 2016

News Industry News

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

January 03, 2016

News Daily News

Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target

Michael O'Riordan

December 21, 2015

News Daily News

先前研究发现肠道细菌动与脉粥样硬化有关，为新药提供了诱人的靶点可能性

Michael O'Riordan

December 21, 2015

News Daily News

Por 1ª Vez unos Estudios asocian las Bacterias Intestinales a la Aterosclerosis y ofrecen una Mirada Asombrosa a una Nueva Diana Farmacológica

Michael O'Riordan

December 21, 2015

News Industry News

FDA approves wearable defibrillator for children at risk for sudden cardiac arrest

December 17, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Michael O'Riordan

December 15, 2015

News Daily News

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

Michael O'Riordan

December 13, 2015

News Daily News

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Michael O'Riordan

December 08, 2015

News Daily News

含糖饮料对全球心脏代谢健康的威胁越来越大

Todd Neale

December 02, 2015

News Daily News

Sugary Drinks an Increasing Threat to Global Cardiometabolic Health

Todd Neale

December 02, 2015

News Daily News

Las Bebidas Azucaradas son una Amenaza contra la Salud Cardiometabólica Global

Todd Neale

December 02, 2015

Advertisement

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)

Refreshed Dietary Guidelines Shift Focus to Healthy Eating Patterns

膳食指南更新版的焦点转向健康饮食习惯

La Actualización de las Directrices sobre la Dieta Cambia el Centro de Atención a Patrones Alimenticios Saludables

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

People Consuming More Sugary Drinks Gain More Visceral Fat Over Time

Sweet Surrender? Trimming Sweetness from Sugary Drinks May Cut Obesity-Related Diseases

Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments

Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target

先前研究发现肠道细菌动与脉粥样硬化有关，为新药提供了诱人的靶点可能性

Por 1ª Vez unos Estudios asocian las Bacterias Intestinales a la Aterosclerosis y ofrecen una Mirada Asombrosa a una Nueva Diana Farmacológica

FDA approves wearable defibrillator for children at risk for sudden cardiac arrest

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

含糖饮料对全球心脏代谢健康的威胁越来越大

Sugary Drinks an Increasing Threat to Global Cardiometabolic Health

Las Bebidas Azucaradas son una Amenaza contra la Salud Cardiometabólica Global

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content